DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER

Clinical safety rating: caution

Comprehensive clinical and safety monograph for DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER (DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER).

How it works

Dextrose 30% in dialysis concentrate provides a hypertonic glucose solution that acts as an osmotic agent to remove fluid and waste products during peritoneal dialysis. It increases the osmolality of the dialysate, creating an osmotic gradient that facilitates ultrafiltration and diffusion of solutes across the peritoneal membrane.

What the body does with it

Metabolism	Dextrose (glucose) is rapidly metabolized via glycolysis and oxidative phosphorylation; primarily taken up by cells and used for energy or stored as glycogen. In peritoneal dialysis, dextrose may be absorbed systemically and contribute to hyperglycemia.
Excretion	Renal: >95% as dextrose and electrolytes; negligible biliary/fecal elimination.
Half-life	Dextrose: 1–2 hours (global metabolism); clinical context: continuous peritoneal dialysis maintains steady state.
Protein binding	Dextrose: negligible (<5%); electrolytes: not bound to proteins.
Volume of Distribution	Dextrose: 0.2–0.3 L/kg (extracellular fluid distribution); electrolytes distribute proportionally to body water.
Bioavailability	Intraperitoneal: near 100% for dextrose and electrolytes; not applicable for other routes.
Onset of Action	Intraperitoneal: 10–30 minutes for ultrafiltration; 30–60 minutes for electrolyte equilibration.
Duration of Action	Intraperitoneal: 4–8 hours (dwell time); varies with solution concentration and patient factors.

Classification & Brands

Dosing & administration

Administered via hemodialysis; dose determined by individual patient requirements, typically 2-3 L of dialysate per treatment session.

Dosage form	SOLUTION
Renal impairment	No dose adjustment needed; used specifically in renal replacement therapy. GFR <15 mL/min: indicated for dialysis.
Liver impairment	No specific Child-Pugh based adjustments; monitor for electrolyte imbalances in hepatic impairment.
Pediatric use	Weight-based dosing; dialysate composition adjusted per pediatric dialysis protocols. Typical volume: 50-100 mL/kg per session.
Geriatric use	Initiate at lower dialysate flow rates; monitor fluid and electrolyte status closely due to increased sensitivity.

Use during pregnancy

1st trimester	Consult provider
2nd trimester	Consult provider
3rd trimester	Consult provider

Clinical note

Comprehensive clinical and safety monograph for DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER (DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER).

Breastfeeding	Dextrose and electrolytes are normal components of breast milk; no expected adverse effects. M/P ratio not applicable.
Teratogenic Risk	No evidence of teratogenicity in animal studies; dextrose is a normal metabolite. However, electrolyte imbalances in mother may affect fetus. Use only if clearly needed.
Fetal Monitoring

Warnings & precautions

■ FDA Black Box Warning

Not for intravenous use. Use only as a component of peritoneal dialysis solutions. Do not use if solution is discolored, cloudy, or contains particulates. Serious complications including peritonitis, fluid overload, and electrolyte imbalances may occur if used improperly.

Side Effect Profile

Serious Effects

Absolute Contraindications

Hypersensitivity to dextrose or any component of the concentrate. Contraindicated in patients with severe hyperglycemia or diabetic ketoacidosis. Do not use in patients with hyperlactatemia or metabolic acidosis unless specifically indicated. Not for use in patients with significant fluid overload where rapid correction is not desired.

Clinical Precautions

Precautions

Monitor blood glucose levels frequently due to risk of hyperglycemia. Assess fluid and electrolyte status regularly. Use caution in patients with impaired glucose tolerance or diabetes mellitus. Monitor for signs of peritonitis (cloudy effluent, abdominal pain). Avoid rapid fluid removal to prevent hypotension. Do not warm solution above 37°C. Single-use only; discard unused portion.

Clinical Tips & Counseling

Drug interactions

Loading safety data…

DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER

Clinical safety rating: caution

Comprehensive clinical and safety monograph for DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER (DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER).

How it works

What the body does with it

Metabolism	Dextrose (glucose) is rapidly metabolized via glycolysis and oxidative phosphorylation; primarily taken up by cells and used for energy or stored as glycogen. In peritoneal dialysis, dextrose may be absorbed systemically and contribute to hyperglycemia.
Excretion	Renal: >95% as dextrose and electrolytes; negligible biliary/fecal elimination.
Half-life	Dextrose: 1–2 hours (global metabolism); clinical context: continuous peritoneal dialysis maintains steady state.
Protein binding	Dextrose: negligible (<5%); electrolytes: not bound to proteins.
Volume of Distribution	Dextrose: 0.2–0.3 L/kg (extracellular fluid distribution); electrolytes distribute proportionally to body water.
Bioavailability	Intraperitoneal: near 100% for dextrose and electrolytes; not applicable for other routes.
Onset of Action	Intraperitoneal: 10–30 minutes for ultrafiltration; 30–60 minutes for electrolyte equilibration.
Duration of Action	Intraperitoneal: 4–8 hours (dwell time); varies with solution concentration and patient factors.

Classification & Brands

Dosing & administration

Administered via hemodialysis; dose determined by individual patient requirements, typically 2-3 L of dialysate per treatment session.

Dosage form	SOLUTION
Renal impairment	No dose adjustment needed; used specifically in renal replacement therapy. GFR <15 mL/min: indicated for dialysis.
Liver impairment	No specific Child-Pugh based adjustments; monitor for electrolyte imbalances in hepatic impairment.
Pediatric use	Weight-based dosing; dialysate composition adjusted per pediatric dialysis protocols. Typical volume: 50-100 mL/kg per session.
Geriatric use	Initiate at lower dialysate flow rates; monitor fluid and electrolyte status closely due to increased sensitivity.

Use during pregnancy

1st trimester	Consult provider
2nd trimester	Consult provider
3rd trimester	Consult provider

Clinical note

Comprehensive clinical and safety monograph for DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER (DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER).

Breastfeeding	Dextrose and electrolytes are normal components of breast milk; no expected adverse effects. M/P ratio not applicable.
Teratogenic Risk	No evidence of teratogenicity in animal studies; dextrose is a normal metabolite. However, electrolyte imbalances in mother may affect fetus. Use only if clearly needed.
Fetal Monitoring